DCF — ATRIUM HEALTH STANLY
Enterprise Value: $130.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$130.4M
Enterprise Value
$35.6M
PV of Cash Flows
$94.9M
PV of Terminal Value
$152.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $116.3M | $15.6M | 13.0% | $7.5M | $6.8M |
| Year 2 | $119.8M | $17.3M | 14.0% | $8.7M | $7.2M |
| Year 3 | $123.4M | $19.1M | 15.0% | $9.8M | $7.4M |
| Year 4 | $127.1M | $20.3M | 16.0% | $10.6M | $7.2M |
| Year 5 | $130.9M | $21.2M | 16.0% | $11.2M | $6.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $130.4M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$113.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.12942456513233463
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5